Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
16
Bearish filings
1
Named actors
13
Disclosed $ (bull / bear)
$60.2M + 3 of unknown size / size unknown
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-18 | Activist (13D) ORBIMED ADVISORS LLC | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-08-17 | 5%+ holder (13G) Vivo Innovation Fund II Holdings, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-13 | Activist (13D) Cormorant Asset Management, LP | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-08-10 | Director ORBIMED ADVISORS LLC | bought | $10.0M | SEC ↗ |
| 2026-08-10 | Director OrbiMed Capital GP VIII LLC | bought | $10.0M | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-10 | Director GORDON CARL L | bought | $10.0M | SEC ↗ |
| 2026-08-10 | 10% owner / other Cormorant Private Healthcare Fund VI, LP | bought | $5.0M | SEC ↗ |
| 2026-08-10 | 10% owner / other Cormorant Asset Management, LP | bought | $5.0M | SEC ↗ |
| 2026-08-10 | 10% owner / other Cormorant Private Healthcare Fund V LP | bought | $5.0M | SEC ↗ |
| 2026-08-10 | Director Chen Bihua | bought | $5.0M | SEC ↗ |
| 2026-08-10 | 10% owner / other Cormorant Global Healthcare Master Fund, LP | bought | $5.0M | SEC ↗ |
| 2026-08-10 | 10% owner / other Cormorant Private Healthcare Fund III LP | bought | $5.0M | SEC ↗ |
| 2026-08-10 | Director Schmid John P. | bought | $96K | SEC ↗ |
| 2026-08-10 | Chief Financial Officer Keyes Jason A | bought | $11K | SEC ↗ |
| 2026-08-10 | General Counsel Liptak Vincent Paul | bought | $35K | SEC ↗ |
| 2026-08-07 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-08-07 | General Counsel Liptak Vincent Paul | bought | $40K | SEC ↗ |